Sort
261,768 grants matching “gene therapy”
Integrative Molecular Profiling of Human Pancreatic Cancer
$1,057,062Syed Perwez Hussain · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer
$1,057,062Syed Perwez Hussain · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Development of humanized models using human induced pluripotent stem cells
$1,056,953John K. Critser · University Of Missouri-Columbia · RC2 · FY2009 · HL
Developing Efficient and Safe Gene Transfer to Primate Hematopoietic Stem Cells
$1,056,912Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
xADAGES III: Contribution of genotype to glaucoma phenotype in African Americans
$1,056,858Robert N Weinreb · University Of California, San Diego · R01 · FY2015 · EY
Chicago Community-Acquired Pneumonia Consortium II
$1,056,782Richard G Wunderink · Northwestern University At Chicago · U18 · FY2011 · IP
Clinical Nutrition Research Unit of Maryland
$1,056,781Susan K Fried · University Of Maryland Baltimore · P30 · FY2006 · DK
MOLECULAR THERAPY FOR CF AND GENETIC DISEASES
$1,056,542University Of Pennsylvania · P30 · FY2003 · DK
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
$1,056,522David A Stoltz · University Of Iowa · R01 · FY2018 · HL
Preclinical drug development in pancreas cancer
$1,056,492Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
India International Center for Excellence in Research
$1,056,353Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Optimizing Novel Dihydroorotate Dehydrogenase Inhibitors for Treating Malaria
$1,056,231Ian Cyril Bathurst · Medicines For Malaria Venture · U01 · FY2007 · AI
Tumor infiltrating lymphocyte therapy for human papillomavirus-positive cancers
$1,056,174Christian Hinrichs · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
T-cell receptor gene therapy for human papillomavirus-positive cancers
$1,056,174Christian Hinrichs · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Gene and Pharmacological Therapies for Cystic Fibrosis
$1,056,163William B. Guggino · Johns Hopkins University · P01 · FY2013 · HL
Preclinical Development of an NT3-expressing HSV Vector
$1,056,121David J. Fink · University Of Michigan At Ann Arbor · U01 · FY2012 · NS
CAREER: Investigating the origins of developmental and regenerative neurogenesis.
$1,056,117Michael J Layden · Lehigh University · · FY2020 · BIO
Mouse Auditory Testing Core Facility
$1,056,061Tracy Fitzgerald · National Institute On Deafness And Other Communication Disorders · ZIC · FY2022 · DC
Studies on oncoprotein-induced feedback: Basic and therapeutic implications
$1,056,048Neal Rosen · Sloan-Kettering Inst Can Research · R35 · FY2022 · CA
Isolation, characterization and translational development of glioma stem cells
$1,056,048Luis F Parada · Sloan-Kettering Inst Can Research · R35 · FY2022 · CA
Isolation, characterization and translational development of glioma stem cells
$1,056,048Luis F Parada · Sloan-Kettering Inst Can Research · R35 · FY2023 · CA
Optimization of Nanoparticle Targeting in Ovarian and Breast Cancer
$1,056,029Tillman Gerngross · Dartmouth College · U54 · FY2011 · CA
Overcoming Resistance to Targeted Therapy in Breast Cancer
$1,056,000Sarat Chandarlapaty · Sloan-Kettering Inst Can Research · R35 · FY2025 · CA
Inflammation-driven T Cell Responses and their Dichotomous Effect on Host Immunity
$1,056,000Martin Prlic · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
The MYC Transcription Factor Network and the Path to Cancer
$1,056,000Robert Neil Eisenman · Fred Hutchinson Cancer Research Center · R35 · FY2020 · CA